Livemint.com -- A group of investors, led by New York-based QVT Financial Lp, is planning to block troubled Indian drug maker Wockhardt Ltd’s Rs620 crore nutrition business divestment deal with US multinational Abbott Laboratories Inc. and any other fresh asset sale till all issues relating to its foreign currency convertible bonds (FCCBs) are resolved.
